CANCER ADVANCES INC has a total of 21 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ARACLON BIOTECH SL, SILER-KHODR THERESA M and XDCEXPLORER SHANGHAI CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Hong Kong | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Grimes Stephen | 13 |
#2 | Osborne Nicholas | 7 |
#3 | Cato Allen | 7 |
#4 | Sutton Lynda | 7 |
#5 | Huber Brian E | 6 |
#6 | Smith Jill P | 5 |
#7 | Michaeli Dov | 3 |
#8 | Makishima Ronald | 3 |
#9 | Gevas Philip C | 3 |
#10 | Watson Susan A | 2 |
Publication | Filing date | Title |
---|---|---|
US2020206332A1 | Compositions and methods for inducing humoral and cellular immunities against tumors and cancer | |
US2010129382A1 | Combination therapy for the treatment of tumors | |
AU2005286164A1 | Monoclonal antibodies to progastrin | |
AU2005228897A1 | Monoclonal antibodies to gastrin hormone | |
AU2004225437A1 | Gastrin hormone immunoassays | |
EP0889735A1 | Immunological methods for the treatment of gastrointestinal cancer |